The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40

BACKGROUND: Tumor debulking surgery followed by adjuvant chemotherapy or radiotherapy is a standard treatment for many solid malignancies. Although this approach can be effective, it often has limited success against recurrent or metastatic cancers and new multimodality approaches are needed. Adjuva...

Descripción completa

Detalles Bibliográficos
Autores principales: Khong, Andrea, Cleaver, Amanda L, Fahmi Alatas, Muhammad, Wylie, Ben C, Connor, Theresa, Fisher, Scott A, Broomfield, Steve, Lesterhuis, Willem J, Currie, Andrew J, Lake, Richard A, Robinson, Bruce W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320570/
https://www.ncbi.nlm.nih.gov/pubmed/25518732
http://dx.doi.org/10.1186/1471-2407-14-969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320570/
https://www.ncbi.nlm.nih.gov/pubmed/25518732
http://dx.doi.org/10.1186/1471-2407-14-969

Ejemplares similares